Author

Barbara T. Grünwald

Observed names: B. Grunwald, Barbara Grunwald, Barbara Grünwald, Barbara T Grünwald, Barbara T. Grunwald, Barbara Theresia Grünwald, Grünwald, Barbara T

Institutions: University Health Network, German Cancer Research Center, Princess Margaret Cancer Centre, Essen University Hospital, West German Heart and Vascular Center Essen, University of Duisburg-Essen

Observed institutions: Ontario Institute for Cancer Research, University Health Network, German Cancer Research Center, University of Toronto, TUM Klinikum, Princess Margaret Cancer Centre, Helmholtz Munich, Essen University Hospital, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Technical University of Munich

ORCID: 0000-0002-7541-5206

Observed ORCID: 0000-0002-7541-5206

OpenAlex ID: A5047728701

Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity

2022 · Kebria Hezaveh, Rahul S. Shinde, et al. · Immunity · 740

Spatially confined sub-tumor microenvironments in pancreatic cancer

2021 · Barbara T. Grünwald, Antoine Devisme, et al. · Cell · 426

PDF

GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer

2020 · Grainne M. O’Kane, Barbara T. Grünwald, et al. · Clinical Cancer Research · 350

PDF

CellViT: Vision Transformers for precise cell segmentation and classification

2024 · Fabian Hörst, Moritz Rempe, et al. · Medical Image Analysis · 342

Tissue inhibitor of metalloproteinases (TIMP)‐1 creates a premetastatic niche in the liver through SDF‐1/CXCR4‐dependent neutrophil recruitment in mice

2014 · Bastian Seubert, Barbara Grünwald, et al. · Hepatology · 213

Nucleic acids from long-term preserved FFPE tissues are suitable for downstream analyses

2012 · Natalie Ludyga, Barbara Grünwald, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 205

Recognizing the Molecular Multifunctionality and Interactome of TIMP-1

2018 · Barbara Grünwald, Benjamin Schoeps, et al. · Trends in Cell Biology · 163

A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer

2020 · Joan M. Romero, Barbara Grünwald, et al. · Clinical Cancer Research · 144

Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver

2016 · Barbara Grünwald, Veronika Harant, et al. · Gastroenterology · 129

Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma

2014 · Sonja Berchtold, Barbara Grünwald, et al. · Cancer Letters · 89

Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer

2016 · Barbara Grünwald, Jennifer Vandooren, et al. · Journal of Controlled Release · 66

Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow

2016 · Barbara Grünwald, Jennifer Vandooren, et al. · Molecular Cancer Research · 59

PDF

TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer

2021 · Chris D. Hermann, Benjamin Schoeps, et al. · The Journal of Experimental Medicine · 53

TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice

2015 · Julia Kobuch, Haissi Cui, et al. · Haematologica · 48

PDF

Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer

2025 · Lukas Klein, Mengyu Tu, et al. · Nature Communications · 44

PDF

The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib

2016 · Annkristin Heine, Judith Schilling, et al. · Cancer Immunology Immunotherapy · 42

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer

2018 · Olga Prokopchuk, Olga Prokopchuk, et al. · BMC Cancer · 39

PDF

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial

2025 · Jennifer J. Knox, Gun Ho Jang, et al. · Nature Communications · 36

PDF

Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model

2016 · Ana Hidalgo-Sastre, Roxanne L. Brodylo, et al. · American Journal Of Pathology · 31

PDF

Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma

2023 · Lucy X. Ma, Yifan Wang, et al. · British Journal of Cancer · 26

PDF

Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers

2023 · Joan Miguel Romero, Emma Titmuss, et al. · npj Precision Oncology · 21

PDF

Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells

2022 · Laura Kuhlmann, Meinusha Govindarajan, et al. · Journal of Proteome Research · 19

An Engineered Paper‐Based 3D Coculture Model of Pancreatic Cancer to Study the Impact of Tissue Architecture and Microenvironmental Gradients on Cell Phenotype

2022 · Jose L. Cadavid, Simon Latour, et al. · Advanced Healthcare Materials · 16

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma

2022 · Bryn Golesworthy, Yifan Wang, et al. · Frontiers in Oncology · 16

Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer

2025 · Csilla Olah, Lara Sichward, et al. · British Journal of Urology · 15

PDF

Works count: 140

Citation count: 3,439

H-index: 21

I10-index: 28